Bridgebio Oncology Therapeutics, Inc. (BBOT)
2.62
-0.08
(-2.96%)
USD |
NASDAQ |
Oct 30, 16:00
2.64
+0.02
(+0.76%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics Market Cap : 209.90M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 209.90M |
| October 29, 2026 | 216.31M |
| October 28, 2026 | 224.32M |
| October 27, 2026 | 215.51M |
| October 26, 2026 | 211.50M |
| October 23, 2026 | 213.11M |
| October 22, 2026 | 228.33M |
| October 21, 2026 | 214.71M |
| October 20, 2026 | 217.91M |
| October 19, 2026 | 228.33M |
| October 16, 2026 | 225.92M |
| October 15, 2026 | 236.34M |
| October 14, 2026 | 232.73M |
| October 13, 2026 | 236.34M |
| October 12, 2026 | 261.17M |
| October 09, 2026 | 265.18M |
| October 08, 2026 | 273.99M |
| October 07, 2026 | 275.60M |
| October 06, 2026 | 280.40M |
| October 05, 2026 | 288.41M |
| October 02, 2026 | 311.65M |
| October 01, 2026 | 315.65M |
| September 30, 2026 | 328.47M |
| September 29, 2026 | 314.05M |
| September 28, 2026 | 305.24M |
| Date | Value |
|---|---|
| September 25, 2026 | 316.45M |
| September 24, 2026 | 319.66M |
| September 23, 2026 | 333.28M |
| September 22, 2026 | 373.34M |
| September 21, 2026 | 373.34M |
| September 18, 2026 | 382.15M |
| September 17, 2026 | 391.76M |
| September 16, 2026 | 381.35M |
| September 15, 2026 | 390.96M |
| September 14, 2026 | 404.58M |
| September 11, 2026 | 396.57M |
| September 10, 2026 | 442.23M |
| September 09, 2026 | 541.18M |
| September 08, 2026 | 709.82M |
| September 04, 2026 | 719.43M |
| September 03, 2026 | 713.02M |
| September 02, 2026 | 712.22M |
| September 01, 2026 | 706.61M |
| August 31, 2026 | 705.01M |
| August 28, 2026 | 700.21M |
| August 27, 2026 | 735.46M |
| August 26, 2026 | 741.86M |
| August 25, 2026 | 750.68M |
| August 24, 2026 | 732.25M |
| August 21, 2026 | 727.44M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Korsana Biosciences, Inc. | 18.33M |
| IRulya Therapeutics, Inc. | 33.51M |
| PepGen Inc. | 163.45M |
| Q32 Bio, Inc. | 211.49M |
| Arrowhead Pharmaceuticals, Inc. | 8.454B |
Market Cap Related Metrics
| Price to Book Value | 0.6496 |
| Price | 2.62 |
| Earnings Yield | -47.05K% |